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ABSTRACT 
The objective of present work was to develop a novel liposomes-based drug delivery system 
for a lipophilic non-steroidal anti-inflammatory drug, piroxicam. The system was prepared 
using proliposomes method and optimised for different preparation parameters including type 
of proliposomes, concentration of drug, duration of hydration and type of particle size 
reduction treatment used. All prepared liposomal samples were extensively characterized for 
their drug-entrapment and size profile using various in-vitro techniques. Present work showed 
that the most optimum formulation (Pro-lipoTM Duo; 12mg piroxicam per gram Pro-lipoTM; 
10 hours hydration time) produced highest amount of actual drug been entrapped in 
liposomes (800.4 mg/g Pro-lipoTM) with a satisfactory entrapment efficiency of 15.36%. 
This formulation had also produced liposomal samples with a homogenous (polydispersity 
index = 0.45) and small particle size (359.95nm). Extrusion technique was found to cause 
significant reduction in drug-entrapment and size profile of drug-loaded liposomes. A 4-
weeks storage study showed that drug-entrapment and size profile of liposomal samples were 
stable in both refrigerated and room temperature. Electron microscopy revealed that prepared 
liposomal samples were spherical-shaped and showed concentric lamellae. In conclusion, 
present work successfully demonstrated a simple, reproducible and practical method of 
preparation for liposomes-encapsulated piroxicam. 
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